DK400088A - Fremstilling og anvendelse af t-cellesuppressorfaktor - Google Patents

Fremstilling og anvendelse af t-cellesuppressorfaktor

Info

Publication number
DK400088A
DK400088A DK400088A DK400088A DK400088A DK 400088 A DK400088 A DK 400088A DK 400088 A DK400088 A DK 400088A DK 400088 A DK400088 A DK 400088A DK 400088 A DK400088 A DK 400088A
Authority
DK
Denmark
Prior art keywords
expressor
factor
cell
manufacturing
expressor factor
Prior art date
Application number
DK400088A
Other languages
English (en)
Other versions
DK400088D0 (da
Inventor
Rainer De Martin
Adriano Fontana
Erhard Hofer
Renate Hofer-Warbinek
Michael Wrann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK400088A publication Critical patent/DK400088A/da
Publication of DK400088D0 publication Critical patent/DK400088D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK400088A 1986-11-17 1988-07-15 Fremstilling og anvendelse af t-cellesuppressorfaktor DK400088D0 (da)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
AT305186 1986-11-17
AT327486 1986-12-10
AT333886 1986-12-16
AT334286 1986-12-16
CH526386 1986-12-31
CH526286 1986-12-31
CH296387 1987-08-03
CH330587 1987-08-28
PCT/EP1987/000716 WO1988003807A2 (en) 1986-11-17 1987-11-16 Production and use of a novel t-cell suppressor factor

Publications (2)

Publication Number Publication Date
DK400088A true DK400088A (da) 1988-07-15
DK400088D0 DK400088D0 (da) 1988-07-15

Family

ID=27569993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK400088A DK400088D0 (da) 1986-11-17 1988-07-15 Fremstilling og anvendelse af t-cellesuppressorfaktor

Country Status (12)

Country Link
EP (1) EP0268561A3 (da)
JP (1) JPH01501361A (da)
KR (1) KR890700031A (da)
AU (1) AU612617B2 (da)
DK (1) DK400088D0 (da)
FI (1) FI883363A (da)
HU (1) HUT57059A (da)
IL (1) IL84484A0 (da)
MY (1) MY102257A (da)
NZ (1) NZ222569A (da)
PT (1) PT86144B (da)
WO (1) WO1988003807A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5284763A (en) * 1985-03-22 1994-02-08 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5221734A (en) * 1987-10-01 1993-06-22 Ciba-Geigy Corporation Process for preparing a polypeptide growth factor for milk
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
US5236905A (en) * 1988-08-25 1993-08-17 Oncogen In vitro method of inhibition of HIV using transforming growth factor-.beta.
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5043431A (en) * 1989-09-11 1991-08-27 Codon Method and apparatus for the production of TGF-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
FR2720069A1 (fr) * 1994-05-19 1995-11-24 Inst Nat Sante Rech Med Dérivés de facteurs de croissance et d'hormones de la superfamille des TGFB, procédé pour leur obtention et leurs applications biologiques.
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
US7101543B2 (en) 2000-03-31 2006-09-05 Novarx Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells
MXPA06011199A (es) 2004-03-31 2007-04-16 Genentech Inc Anticuerpos anti-tgf-beta humanizados.
KR20090105913A (ko) 2006-11-02 2009-10-07 다니엘 제이 카폰 이동 부분을 갖는 하이브리드 면역글로불린
WO2018203541A1 (ja) * 2017-05-02 2018-11-08 株式会社カネカ 免疫グロブリン結合活性を有するポリペプチドの回収精製法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341401C (en) * 1984-03-23 2002-11-26 Adriano Fontana Immunosuppressant factor derived from human glioblastoma cells
EP0155433A1 (en) * 1984-03-23 1985-09-25 Adriano Fontana Immunosuppressant factor
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
AU630075B2 (en) * 1987-10-06 1992-10-22 Bristol-Myers Squibb Company Cloning and expression of transforming growth factor 2b

Also Published As

Publication number Publication date
MY102257A (en) 1992-05-15
WO1988003807A2 (en) 1988-06-02
WO1988003807A3 (en) 1988-08-11
AU612617B2 (en) 1991-07-18
AU1104988A (en) 1988-06-16
DK400088D0 (da) 1988-07-15
PT86144B (pt) 1990-08-31
KR890700031A (ko) 1989-03-02
PT86144A (en) 1987-12-01
EP0268561A3 (en) 1988-10-26
NZ222569A (en) 1990-08-28
HUT57059A (en) 1991-11-28
FI883363A0 (fi) 1988-07-14
JPH01501361A (ja) 1989-05-18
IL84484A0 (en) 1988-04-29
EP0268561A2 (en) 1988-05-25
FI883363A (fi) 1988-07-14

Similar Documents

Publication Publication Date Title
IT1205010B (it) Tetraidronaftalin-derivati e indan-derivati
DK302187A (da) Indretning til fastholdelse af et kateter og fremgangsmaade til fremstilling af samme indretning
DK17787A (da) Phenylurinstoffer
DK106191D0 (da) Mellemprodukter til fremstilling af penemer og carbapenemer
DK400088A (da) Fremstilling og anvendelse af t-cellesuppressorfaktor
DK324387A (da) Aza-bicycliske forbindelser
DK154523C (da) Laasering og anvendelse af laaseringen
DK313787A (da) Muffesamling og fremgangsmaade til fremstilling af samme
DK413187A (da) Semicarbazoner og thiosemicarbazoner
DK28883A (da) Dentalkonstruktion og fremgangsmaade til fremstilling af samme
NO881902D0 (no) Sopparoma og fremstilling derav.
DK75290D0 (da) Stoebt boerste og fremgangsmaade til fremstilling af samme
DK215988D0 (da) Fotokemigrafiemmer og fremgangsmaader til fremstilling af saadanne emner
TR23713A (tr) Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
DK289987A (da) Anvendelse af avaron- og avarolderivater
DK289887A (da) Anvendelse af avaron- og avarolderivater
DK2388A (da) Fremstilling af polyethermaterialer
DK674787D0 (da) Herbicidkomposition og fremgangsmaade til anvendelse af samme
FR2593744B1 (fr) Agenda
DK464388D0 (da) Emne af formstof
SE8601927D0 (sv) Festelement
BR8601118A (pt) Imantador e desimantador
DK448388D0 (da) Kateter og fremgangsmaade til fremstilling af samme
DK396683D0 (da) Inclusionskompleks og fremgangsmade til fremstilling af samme
DK621088D0 (da) Theemballage af theposetypen

Legal Events

Date Code Title Description
ATS Application withdrawn
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment